Consulting Case Interview by Bain Associate Consultant 

Same thought here!

Trouble + huge investment of time , $$, and resources.

You should count no more than 60-90 seconds to lay down your structure, you can gain 60 more seconds if you’re completely able to discuss with your interviewer while you’re writing it down

you get 120 secs if you are lookin hot

It was so annoying

Like my comment below, you should consider asking more clarifying questions upfront (Ex. "How are other firms treating migraine now? With other substances?"). Since Migraine is merely a disease (extreme headache), you can actually treat it with existing medicine you can find in CVS or Walgreens. Therefore, you should not assume that your client can enjoy 100% market share. She is saying that a 30% share is not too excessive because BoTox is a product line registered with a trademark by AbbVie, the 6th largest medical company in North America. Nevertheless, I think she went a tad aggressive. I would've picked 10% or 15% (at that moment, since I would've asked competitive landscape in the later bucket) since there are quite a number of giant medicine groups. But whenever the interviewer says OK, you are fine with whatever number you choose.

I think many of her assumptions are not that reasonable, sometimes maybe the interviewer only cares about the analyzing process but not the figures.

I think she assumes that the company could potentially get upto a 30% market share which is much on the higher side as the market is not growing and there are existing established competitors

I know what you are saying. Unlike her, you, who are not familiar with the medical lexicon, should ask additional clarifying questions upfront. Migraine is essentially a severe headache. Botulinum Toxin (BoTox) is both the name of the wrinkle-removing toxin and the name of the company. So she is right that the objective of this case is to estimate the BoTox injections market geared toward resolving migraine. It may be a surprise that this toxin is indeed used to treat some severe headaches.

Did not get why she analysed the Botox market if the question was entering a new market..@@1Piece_Luffy

She does talks about market size, competition, price elasticity, us population, people suffering from headaches, total no of patients, injections per patient. So isn’t that top down approach?

I feel insurance companies should not have been overlooked